Diabetes news from the American Diabetes Association
Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.
Latest Top (10) News
Clinical trials testing therapies for diabetes
Latest Top (10) News
Adapting Critical Time Intervention to Support Inpatient Medical Care Transition Conditions: Schizophrenia; Ambulatory Care Sensitive Conditions Intervention: Other: Critical time intervention Sponsors: New York State Psychiatric Institute; Healthfirst; Montefiore Medical Center; Bronx-Lebanon Hospital Center Health Care System Not yet recruiting
Fri, 17 Aug 2018 12:00:00 EDT Cell Therapy for Peripheral Arterial Disease and Diabetes Conditions: Peripheral Arterial Disease; Diabetes Mellitus Intervention: Procedure: celular therapy Sponsors: Hospital Regional de Alta Especialidad del Bajio; Instituto Mexicano del Seguro Social Active, not recruiting
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Fri, 17 Aug 2018 09:46:00 -0400 FDA approves first generic version of EpiPen FDA approves the first generic version of EpiPen and EpiPen Jr for the emergency treatment of allergic reactions in adults and pediatric patients who weigh more than 33 pounds.
Fri, 10 Aug 2018 16:37:00 -0400 FDA approves new vaginal ring for one year of birth control FDA approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.
Fri, 10 Aug 2018 13:54:00 -0400 FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease FDA approves new drug for treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR). This is the first FDA-approved treatment for this rare, debilitating and often fatal genetic disease and the first FDA approval of a new class of drugs called small interfering ribonucleic acid (siRNA) treatment.
